Litcius/Paper detail

Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial

Deanna L. Kelly, Matthew Glassman, Ikwunga Wonodi, Gopal Vyas, Charles M. Richardson, Evaristus Nwulia, Heidi J. Wehring, Taiwo Oduguwa, Marie Mackowick, Maria Hipolito, Olawunmi Peters, Narayan Rai, Jaeboon Park, Adeola Adebayo, David A. Gorelick, Elaine Weiner, Fang Liu, Ann Marie Kearns, Heather A. Adams, Raymond C. Love, Shuo Chen, Ayodeji Olaniyan, Nicholas P. Ambulos, Darius McKoy, Madhulika C. Nallani, Sophie Lanzkron, Mulu Mengistab, Brian Barr, Erica Davis, Rahman Lawal, Robert W. Buchanan, Richard A. Adebayo

2023Schizophrenia Research22 citationsDOIOpen Access PDF

Topics & Concepts

ClozapineNeutropeniaInternal medicineMedicinePopulationDiscontinuationGenotypeGastroenterologySchizophrenia (object-oriented programming)PsychiatryBiologyChemotherapyGeneticsEnvironmental healthGeneBlood disorders and treatmentsSchizophrenia research and treatmentAcute Myeloid Leukemia Research
Clozapine and neutrophil response in patients of African descent: A six-month, multinational, prospective, open-label clinical trial | Litcius